With Wim Van Camp joining, Qbic brings in more expertise on academic partnerships and biotech R&D.
BELGIUM – Ghent, 3 November 2022 - Qbic Fund welcomes Wim Van Camp as new Managing Partner. Qbic was launched in 2012 as an inter-university initiative from Ghent University, VUB and University of Antwerp. Since then, the fund has expanded its network to include fifteen universities, research institutes and hospitals across Belgium. In March 2022, Qbic has launched its third fund, with an initial capital of 49 M Euro. In order to support its growth, the fund was looking for reinforcement. They found that in Wim Van Camp, who is no stranger to Qbic. As a Board representative for Ghent University, Wim Van Camp has been involved in Qbic since 2014. He will now take up an active role in the fund as Managing Partner.
Qbic is a venture capital fund focusing on the transformation of technological breakthroughs into societal and environmental impact. ”The number of knowledge partners in our network has been increasing over the years”, clarifies Sofie Baeten, Managing Partner at Qbic. “Our knowledge partners are instrumental for the dealflow of our funds. With Wim, we have the right person on board to manage these partnerships.”
With the hiring of Wim Van Camp, Qbic is also adding expertise in life sciences to its team. “With more than 15 years of industrial experience in biotech companies of different size and maturity, I have a good understanding of the challenges that these companies are facing during their growth trajectory. I see it as my role to ensure that the go-to-market strategy of our portfolio companies always comes first, both at Board level and in the projects,” adds Wim Van Camp.
PharmaFluidics developed a complementary range of reversed-phase chromatography columns for systems biology and biopharma applications.